(Q37346005)

19 August 2017

1 reference

title

Treatment strategies for recurrent and refractory Clostridium difficile-associated diarrhea (English)

1 reference

19 August 2017

0 references

Clostridium difficile

0 references

author

Christina M. Surawicz

series ordinal

2

object named as

Christina M Surawicz

1 reference

19 August 2017

Crenguta Stepan

1

1 reference

19 August 2017

publication date

1 December 2007

1 reference

Expert Review of Gastroenterology & Hepatology

19 August 2017

published in

1 reference

19 August 2017

volume

1

1 reference

19 August 2017

issue

2

1 reference

19 August 2017

page(s)

295-305

1 reference

Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Nosocomial acquisition of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Clostridium difficile-associated diarrhea in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Evaluation of three rapid assays for detection of Clostridium difficile toxin A and toxin B in stool specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Evaluation of real-time PCR and conventional diagnostic methods for the detection of Clostridium difficile-associated diarrhoea in a prospective multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Nitazoxanide for the treatment of Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Comparison of the in vitro activities of teicoplanin and vancomycin against Clostridium difficile and their interactions with cholestyramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Intravenous metronidazole for the treatment of Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Corticosteroid treatment of severe, non-responsive Clostridium difficile induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Recurrent Clostridium difficile diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Experimental effects of Saccharomyces boulardii on diarrheal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Recurrent Clostridium difficile infection in a patient with selective IgG1 deficiency treated with intravenous immune globulin and Saccharomyces boulardii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Intravenous immunoglobulin for recurrent Clostridium difficile diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile-associated diarrhoea: preclinical and preliminary clinical data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Active and passive immunization against Clostridium difficile diarrhea and colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Ramoplanin: a topical lipoglycodepsipeptide antibacterial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

Failure of dietary oligofructose to prevent antibiotic-associated diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.2.295

21 January 2018

Identifiers

DOI

10.1586/17474124.1.2.295

1 reference

19 August 2017

1 reference